6/19
08:00 am
jspr
Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
Medium
Report
Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
6/18
10:03 am
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
6/17
04:30 pm
jspr
Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
Medium
Report
Jasper Therapeutics to Present at the Oppenheimer Novel Targets in Immunology Summit
6/14
08:13 am
jspr
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress [Yahoo! Finance]
Low
Report
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress [Yahoo! Finance]
6/14
08:00 am
jspr
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
Low
Report
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
6/9
10:50 am
jspr
Here's Why We're Not Too Worried About Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Situation [Yahoo! Finance]
Low
Report
Here's Why We're Not Too Worried About Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Situation [Yahoo! Finance]
5/30
06:11 pm
jspr
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 [Yahoo! Finance]
Medium
Report
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 [Yahoo! Finance]
5/30
06:05 pm
jspr
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
Medium
Report
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
5/14/2024
08:00 am
jspr
jasper therapeutics, inc. - class a
BEAT
Report
-2.6%
jasper therapeutics, inc. - class a
6/20
06:08 am
jspr
Form 4 Jasper Therapeutics, For: Jun 18 Filed by: Lucas Svetlana
Medium
Report
Form 4 Jasper Therapeutics, For: Jun 18 Filed by: Lucas Svetlana
6/20
06:06 am
jspr
Form 3 Jasper Therapeutics, For: Jun 18 Filed by: Lucas Svetlana
Medium
Report
Form 3 Jasper Therapeutics, For: Jun 18 Filed by: Lucas Svetlana
6/20
06:03 am
jspr
Form 8-K Jasper Therapeutics, For: Jun 17
Medium
Report
Form 8-K Jasper Therapeutics, For: Jun 17
6/12
09:41 pm
jspr
Form 4 Jasper Therapeutics, For: Jun 12 Filed by: Mahal Jeetinder Singh
Low
Report
Form 4 Jasper Therapeutics, For: Jun 12 Filed by: Mahal Jeetinder Singh
6/12
09:31 pm
jspr
Form 144 Jasper Therapeutics, Filed by: Mahal Jeetinder Singh
Low
Report
Form 144 Jasper Therapeutics, Filed by: Mahal Jeetinder Singh
6/12
04:09 pm
jspr
Form 4 Jasper Therapeutics, For: Jun 10 Filed by: MARTELL RON
Low
Report
Form 4 Jasper Therapeutics, For: Jun 10 Filed by: MARTELL RON
6/12
08:01 am
jspr
Form 8-K Jasper Therapeutics, For: Jun 06
Medium
Report
Form 8-K Jasper Therapeutics, For: Jun 06
6/10
06:32 pm
jspr
Form 4 Jasper Therapeutics, For: Jun 07 Filed by: Tucker Edwin Jonathan
Low
Report
Form 4 Jasper Therapeutics, For: Jun 07 Filed by: Tucker Edwin Jonathan
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register